CanSino Biologics, Inc. Class H (HK:6185) has released an update.
CanSino Biologics, Inc. successfully held its 2023 Annual General Meeting (AGM) with all proposed resolutions passed by poll, including the election of Mr. Chi Shing LI as the new non-executive Director of the Board. The AGM saw a healthy turnout with over 34% of share capital represented. The company confirms full compliance with voting regulations, with no shareholders required to abstain or vote against the resolutions.
For further insights into HK:6185 stock, check out TipRanks’ Stock Analysis page.
